Perez Daniel Antonio sold $13.4M of HNGE (indirect holdings)

Perez Daniel Antonio (CEO & Co-Founder) sold 150,000 indirectly-held shares of Hinge Health, Inc. (HNGE) at an average of $89.44 ($88.22–$91.60, $13.42M total) across 5 trades on 2026-09-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Perez Daniel Antonio
Published Sep 11, 2026, 11:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 11:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$HNGE
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

Potential short‑term pressure on Hinge Health stock if publicly traded; otherwise limited effect.

02

Market read

Primary disclosure of a sizable insider sale; relevance mainly to investors holding Hinge Health.

03

What to watch

10b5-1 plan pre‑arranged; may not reflect insider sentiment.

Relevance 6/10Novelty 6/10Timing: filing 2026-09-11

Background

SEC Form 4 filing by CEO Daniel Antonio showing a $13.4M open‑market sale of Hinge Health shares.

Market effects

Insider sell may signal concerns for digital health sector.

Limited to U.S. investors tracking Hinge Health.

Minimal global impact.

Counterpoint

Sale could be a routine liquidity event, not a bearish signal.

Key entities

  • Daniel Antonio Perez

    CEO & Co‑Founder of Hinge Health

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNGEHighAI 8/10

Needham raises Hinge Health stock price target on client growth

Needham raised its price target for Hinge Health (NYSE:HNGE) to $135 from $115, citing strong client growth and quarterly performance. The company reported 28% year-over-year client growth, 50% revenue increase, and 154% stock return over six months. Q3 revenue was $235 million, up 52% year-over-year, with EPS of $0.66 beating estimates. Wells Fargo also raised its target to $132, noting strong margins and revenue growth.

$HNGEHighAI 8/10

Hinge Health (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health (HNGE) reported Q3 2026 revenue of $235M, up 52% YoY, with gross margin at 88% and operating income at $77M. The company highlighted growth in its MSK, Migraine, and GI care programs, with strong early results in Migraine care. President Jim Pursley announced his departure at year-end to spend more time with family but will join the board.